H.U. Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. It operates through the following segments: Contracted Clinical Testing, Clinical Laboratory Testing, Sterilization related, New Development Business and Others. The Contracted Clinical Testing segment offers clinical laboratory testing services; collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back. The Clinical Laboratory Testing segment develops, manufactures and sales diagnostic products globally that are used at medical field for early detection and diagnosis. The Sterilization related segment provides general solutions to the issues facing operating rooms and central materials rooms. It establishes new out-of-hospital centers and promoting automation of operations. The New Development Business and Others segment pertains to newly established food, environment and cosmetic inspection businesses. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company